Pfizer and GSK to battle for share of new RSV vaccine market: Report
New Delhi, June 13 (SocialNews.XYZ) US drugmaker Pfizers and British pharma major GSK are likely to face significant competition in the respiratory syncytial virus (RSV) vaccine market, according to a report on Tuesday. GSK’s novel…



















